Neurocrine Biosciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
2,356.49 |
2,784.14 |
3,199.16 |
3,580.61 |
3,966.70 |
4,167.29 |
| Przychód Δ r/r |
0.00% |
18.15% |
14.91% |
11.92% |
10.78% |
5.06% |
| Przychód (min) |
2,336.52 |
2,583.12 |
2,813.20 |
3,569.48 |
3,667.07 |
3,852.51 |
| Przychód (max) |
2,366.47 |
2,844.45 |
3,402.80 |
3,591.74 |
4,123.61 |
4,332.14 |
| EBITDA (średnia) |
543.57 |
642.21 |
737.95 |
825.93 |
914.99 |
961.26 |
| EBIT (średnia) |
519.48 |
613.75 |
705.24 |
789.33 |
874.44 |
918.66 |
| EBIT % |
22.04% |
22.04% |
22.04% |
22.04% |
22.04% |
22.04% |
| Zysk netto (średni) |
348.30 |
459.37 |
654.16 |
859.75 |
1,095.33 |
1,213.98 |
| Zysk netto % |
14.78% |
16.50% |
20.45% |
24.01% |
27.61% |
29.13% |
| EPS (średnia) |
3.95 |
4.43 |
6.45 |
8.33 |
10.56 |
11.71 |
| Liczba analityków (Przychody) |
18 |
17 |
23 |
19 |
8 |
10 |
| Liczba analityków (EPS) |
14 |
13 |
17 |
15 |
7 |
10 |
| symbol |
NBIX |
NBIX |
NBIX |
NBIX |
NBIX |
NBIX |